222 related articles for article (PubMed ID: 9820479)
1. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells.
Brossay L; Naidenko O; Burdin N; Matsuda J; Sakai T; Kronenberg M
J Immunol; 1998 Nov; 161(10):5124-8. PubMed ID: 9820479
[TBL] [Abstract][Full Text] [Related]
2. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
Burdin N; Brossay L; Koezuka Y; Smiley ST; Grusby MJ; Gui M; Taniguchi M; Hayakawa K; Kronenberg M
J Immunol; 1998 Oct; 161(7):3271-81. PubMed ID: 9759842
[TBL] [Abstract][Full Text] [Related]
3. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.
Singh N; Hong S; Scherer DC; Serizawa I; Burdin N; Kronenberg M; Koezuka Y; Van Kaer L
J Immunol; 1999 Sep; 163(5):2373-7. PubMed ID: 10452969
[TBL] [Abstract][Full Text] [Related]
4. Glycolipid antigen processing for presentation by CD1d molecules.
Prigozy TI; Naidenko O; Qasba P; Elewaut D; Brossay L; Khurana A; Natori T; Koezuka Y; Kulkarni A; Kronenberg M
Science; 2001 Jan; 291(5504):664-7. PubMed ID: 11158680
[TBL] [Abstract][Full Text] [Related]
5. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
6. Surprisingly minor influence of TRAV11 (Valpha14) polymorphism on NK T-receptor mCD1/alpha-galactosylceramide binding kinetics.
Sim BC; Holmberg K; Sidobre S; Naidenko O; Niederberger N; Marine SD; Kronenberg M; Gascoigne NR
Immunogenetics; 2003 Mar; 54(12):874-83. PubMed ID: 12671739
[TBL] [Abstract][Full Text] [Related]
7. The surprising diversity of lipid antigens for CD1-restricted T cells.
Moody DB
Adv Immunol; 2006; 89():87-139. PubMed ID: 16682273
[TBL] [Abstract][Full Text] [Related]
8. CD1 proteins: targets of T cell recognition in innate and adaptive immunity.
Ulrichs T; Porcelli SA
Rev Immunogenet; 2000; 2(3):416-32. PubMed ID: 11256748
[TBL] [Abstract][Full Text] [Related]
9. Effects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cells.
Goff RD; Gao Y; Mattner J; Zhou D; Yin N; Cantu C; Teyton L; Bendelac A; Savage PB
J Am Chem Soc; 2004 Oct; 126(42):13602-3. PubMed ID: 15493902
[TBL] [Abstract][Full Text] [Related]
10. The paradox of immune molecular recognition of alpha-galactosylceramide: low affinity, low specificity for CD1d, high affinity for alpha beta TCRs.
Cantu C; Benlagha K; Savage PB; Bendelac A; Teyton L
J Immunol; 2003 May; 170(9):4673-82. PubMed ID: 12707346
[TBL] [Abstract][Full Text] [Related]
11. The crystal structure of human CD1d with and without alpha-galactosylceramide.
Koch M; Stronge VS; Shepherd D; Gadola SD; Mathew B; Ritter G; Fersht AR; Besra GS; Schmidt RR; Jones EY; Cerundolo V
Nat Immunol; 2005 Aug; 6(8):819-26. PubMed ID: 16007090
[TBL] [Abstract][Full Text] [Related]
12. CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: lymphocytes of innate immunity.
Benlagha K; Bendelac A
Semin Immunol; 2000 Dec; 12(6):537-42. PubMed ID: 11145859
[TBL] [Abstract][Full Text] [Related]
13. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells.
Carnaud C; Lee D; Donnars O; Park SH; Beavis A; Koezuka Y; Bendelac A
J Immunol; 1999 Nov; 163(9):4647-50. PubMed ID: 10528160
[TBL] [Abstract][Full Text] [Related]
15. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.
Jahng A; Maricic I; Aguilera C; Cardell S; Halder RC; Kumar V
J Exp Med; 2004 Apr; 199(7):947-57. PubMed ID: 15051763
[TBL] [Abstract][Full Text] [Related]
16. The in vivo response of invariant natural killer T cells to glycolipid antigens.
Parekh VV; Lalani S; Van Kaer L
Int Rev Immunol; 2007; 26(1-2):31-48. PubMed ID: 17454263
[TBL] [Abstract][Full Text] [Related]
17. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
18. Structural requirements for antigen presentation by mouse CD1.
Burdin N; Brossay L; Degano M; Iijima H; Gui M; Wilson IA; Kronenberg M
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10156-61. PubMed ID: 10963678
[TBL] [Abstract][Full Text] [Related]
19. Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules.
Denkberg G; Stronge VS; Zahavi E; Pittoni P; Oren R; Shepherd D; Salio M; McCarthy C; Illarionov PA; van der Merwe A; Besra GS; Dellabona P; Casorati G; Cerundolo V; Reiter Y
Eur J Immunol; 2008 Mar; 38(3):829-40. PubMed ID: 18253930
[TBL] [Abstract][Full Text] [Related]
20. TCR beta chain influences but does not solely control autoreactivity of V alpha 14J281T cells.
Gui M; Li J; Wen LJ; Hardy RR; Hayakawa K
J Immunol; 2001 Dec; 167(11):6239-46. PubMed ID: 11714786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]